
Anna K. Winge-Main
- Consultant, PhD student; MD
- +47 22 78 11 62
HELSE SØR ØST
Education:
- September 2019 – ongoing: PhD student Dept. of Cellular Therapy, OUS-Radiumhospitalet, Oslo, Norway
- December 2013: GMC registered Specialist in Clinical Oncology, UK.
- April 2011: Specialist in Oncology, Norway
- 2002: Certified Doctor in Norway
- 1995 – 2002: Medical studies, Semmelweis University of Medicine, Budapest, Hungary
Research interest/projects:
- Development of Therapeutic TCR against malignant melanoma
- (Principal) investigator for several melanoma trials with immunotherapy and targeted therapies
- General interest in immunotherapy and stereotactic radiation therapy in clinic practice
Work experience:
- April 2017- ongoing: Clinical Lead oncological melanoma treatment, Oslo University Hospital, Department of Oncology
- August 2014 – ongoing: Consultant for melanoma, Oslo University Hospital, Department of Oncology
- 2010 – May 2011: Locum Consultant urooncology, Oslo University Hospital, Department of Oncology
- 2009 – okt.2010: Junior Doctor, Oslo University Hospital, Department of Oncology
- 2005 – Sept 2008: Junior Doctor, Oslo University Hospital, Department of Oncology
- 2004 – July 2005: Junior Doctor, Ringerike Hospital, Department of Internal Medicine, Hønefoss, Norway
- 2004 – Aug. 2004: Inter Doctor, General Medical Practice, Torget Legesenter, Askim, Norway
- 2003 – Jan. 2004: Intern Doctor, Sykehuset i Øsfold, Department of Internal Medicine and Department of Surgery, Fredrikstad, Norway
- 2002 – Dec. 2002: Locum Junior Doctor, Ringerike Hospital, Department of Internal Medicine, Hønefoss, Norway
Publications 2021
Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
BMJ Case Rep, 14 (5)
DOI 10.1136/bcr-2021-241981, PubMed 34045201
Publications 2020
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther, 29 (3), 1199-1213
DOI 10.1016/j.ymthe.2020.11.019, PubMed 33212301
T cell receptor therapy against melanoma-Immunotherapy for the future?
Scand J Immunol, 92 (4), e12927
DOI 10.1111/sji.12927, PubMed 32640053
Publications 2010
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733